| 1 |
25719307 | Pharmacogenetics of drug oxidation via cytochrome P450 (CYP) in the populations of Denmark, Faroe Islands and Greenland. | 2015 Sep |
1 |
| 2 |
24492587 | Effect of cytochrome P450 2C19 and 2C9 amino acid residues 72 and 241 on metabolism of tricyclic antidepressant drugs. | 2014 |
1 |
| 3 |
23486447 | Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. | 2013 May |
1 |
| 4 |
28520379 | Imipramine Therapy and CYP2D6 and CYP2C19 Genotype | 2012 |
2 |
| 5 |
19884907 | The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients. | 2010 Jun |
7 |
| 6 |
17667959 | Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients. | 2008 Jun |
2 |
| 7 |
15199661 | Some aspects of genetic polymorphism in the biotransformation of antidepressants. | 2004 Jan-Feb |
1 |
| 8 |
14640711 | Chip-based P450 drug metabolism coupled to electrospray ionization-mass spectrometry detection. | 2003 Dec 1 |
1 |
| 9 |
12065442 | Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. | 2002 Jul |
1 |
| 10 |
12228186 | Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin. | 2002 Oct |
1 |
| 11 |
10886465 | Pharmacogenetics and psychopharmacotherapy. | 2000 Jun |
1 |
| 12 |
10411572 | A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. | 1999 Aug |
1 |
| 13 |
9923577 | Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro. | 1998 Nov-Dec |
1 |
| 14 |
9084457 | Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4. | 1997 Mar |
2 |
| 15 |
9316174 | Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy. | 1997 Aug |
5 |
| 16 |
8835703 | Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients. | 1996 Aug |
4 |
| 17 |
8521680 | Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. | 1995 Sep |
1 |
| 18 |
8806399 | Cytochrome P450 isozymes and antiepileptic drug interactions. | 1995 |
1 |
| 19 |
8846618 | Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. | 1995 |
1 |
| 20 |
8198931 | The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation. | 1994 Mar |
2 |